These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29433569)

  • 1. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
    Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.
    Pohland M; Hagl S; Pellowska M; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Neurochem Res; 2016 Feb; 41(1-2):231-42. PubMed ID: 26721513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease.
    Eckert GP; Eckert SH; Eckmann J; Hagl S; Muller WE; Friedland K
    Exp Neurol; 2020 Jul; 329():113286. PubMed ID: 32199815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
    Robinson A; Grösgen S; Mett J; Zimmer VC; Haupenthal VJ; Hundsdörfer B; Stahlmann CP; Slobodskoy Y; Müller UC; Hartmann T; Stein R; Grimm MO
    Aging Cell; 2014 Apr; 13(2):263-72. PubMed ID: 24304563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
    Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
    Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF
    FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models.
    Gong B; Pan Y; Vempati P; Zhao W; Knable L; Ho L; Wang J; Sastre M; Ono K; Sauve AA; Pasinetti GM
    Neurobiol Aging; 2013 Jun; 34(6):1581-8. PubMed ID: 23312803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
    Sheng B; Wang X; Su B; Lee HG; Casadesus G; Perry G; Zhu X
    J Neurochem; 2012 Feb; 120(3):419-29. PubMed ID: 22077634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    Martire S; Fuso A; Mosca L; Forte E; Correani V; Fontana M; Scarpa S; Maras B; d'Erme M
    J Alzheimers Dis; 2016 Aug; 54(1):307-24. PubMed ID: 27567805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of MH84, a γ-secretase modulator with PPARγ agonistic activity.
    Pellowska M; Stein C; Pohland M; Merk D; Klein J; Eckert GP; Schubert-Zsilavecz M; Wurglics M
    J Pharm Biomed Anal; 2015 Jan; 102():417-24. PubMed ID: 25459941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
    Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
    J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
    Kumar S; Reddy AP; Yin X; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
    Dixit S; Fessel JP; Harrison FE
    Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
    Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
    J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.